Clinical Trial Update: Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving Immunotherapy [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update assessing safety and efficacy of Bifidobacterium therapy in patients with advanced hepatocellular carcinoma undergoing immunotherapy (Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Bifidobacterium therapy (Bifidobacterium)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Advanced Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN